Quest Diagnostics, Inc. (DGX) Tops Q1 EPS by 6c; Raises FY12 Outlook

Quest Diagnostics, Inc. (NYSE: DGX) reported Q1 EPS of $1.07, $0.06 better than the analyst estimate of $1.01. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.88 billion.

Raises its FY12 EPS guidance to $4.45-$4.60, which compares to the Street estimate of $4.54. The company previously guided to $4.40-$4.55.

For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• CPS Technologies (CPSH) Reports In-Line Q3 EPS
• Intel shares fall as competitor reports record results
• Reynolds Consumer Products Inc. (REYN) Tops Q3 EPS by 1c, Beats on Revenue; Offers FY26 EPS Guidance